Acorda Therapeutics, Inc.
Records under this name other than the patents Acorda Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Back to Acorda Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,943,166 | Methods and Compositions for Administration of TRPV1 Agonists Formerly held In force · High confidence | In force | High confidence | |
| US 12,029,820 | Sustained release compositions of 4-aminopyridine Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,956,266 | Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure Lapsed on the fee record Ended May 1, 2026 · USPTO record | Lapsed on the fee record | Ended May 1, 2026 | USPTO record |
| US 9,951,001 | Hepatoprotectant Acetaminophen Mutual Prodrugs Lapsed on the fee record Ended Apr 24, 2026 · High confidence | Lapsed on the fee record | Ended Apr 24, 2026 | High confidence |
| US 11,235,031 | Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure Lapsed on the fee record Ended Feb 1, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 1, 2026 | USPTO record |
| US 8,628,929 | Methods for detecting cardiac damage Lapsed on the fee record Ended Jan 14, 2026 · USPTO record | Lapsed on the fee record | Ended Jan 14, 2026 | USPTO record |
| US 9,834,764 | Compositions and methods of using chondroitinase ABCI mutants Lapsed on the fee record Ended Dec 5, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 5, 2025 | USPTO record |
| US 11,136,342 | Carbonate Prodrugs and Methods of Using the Same Lapsed on the fee record Ended Oct 5, 2025 · High confidence | Lapsed on the fee record | Ended Oct 5, 2025 | High confidence |
| US 9,757,429 | Methods for detecting cardiac damage Lapsed on the fee record Ended Sep 12, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2025 | USPTO record |
| US 9,744,215 | Method for achieving desired glial growth factor 2 plasma levels Lapsed on the fee record Ended Aug 29, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 29, 2025 | USPTO record |